Shamrock Industrial Company Limited

Equities

SHAMROIN

INE022F01015

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:53 2024-05-13 EDT 5-day change 1st Jan Change
12.13 INR 0.00% Intraday chart for Shamrock Industrial Company Limited 0.00% +49.20%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Shamrock Industrial Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Shamrock Industrial Company Limited Announces Directorate Appointments CI
Shamrock Industrial's Managing Director Steps Down MT
Shamrock Industrial Company Limited Announces the Resignation of Kamlesh R. Khokhani as Managing Director CI
Shamrock Industrial Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Shamrock Industrial Company Limited Announces Board Changes CI
Shamrock Industrial Company Limited Announces Board Changes CI
Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Shamrock Industrial Co. Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015 CI
Shamrock Industrial Co. Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014 CI
Shamrock Industrial Co. Ltd. Announces Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2014 CI
Shamrock Industrial Company Ltd Reports Unaudited Standalone/Consolidated Earnings Results for the First Quarter Ended June 30, 2014 CI
Shamrock Industrial Co. Ltd. Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone Earnings Results for the Full Year Ended March 31, 2014 CI
Shamrock Industrial Co. Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended Dec. 31, 2013 CI
Shamrock Industrial Company Ltd Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2013 CI
Shamrock Industrial Company Ltd Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Audited Consolidated Earnings for the Full Year Ended March 31, 2013 CI
Chart Shamrock Industrial Company Limited
More charts
Shamrock Industrial Company Limited (SICL) is an India-based company, which is a trader of pharmaceuticals products. The Company offers a range of manufacturing of pharmaceuticals and drugs products, and allied business activities. The Company's division include Bulk, Pharmaceuticals and Chemicals Division (BPC), Medivet, Research and Development, ERP, Nviro Chemstock and Nutrasciences. BPC comprises of manufacturing and contract manufacturing of active pharmaceutical ingredients (APIs), advance intermediates, intermediates and fine chemicals. It consists of manufacturing, contract manufacturing and outsourcing products. Medivet division's product range comprise of potent and healthy anthelmintic range. Nviro Chemstock is engaged in exports contract manufacturing API, Intermediates and fine chemicals. The Company's customer portfolio consists of generic API producers, multinational companies, finished formulations manufacturers, and distributers.
Calendar
More about the company